Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation
Authors
Keywords
-
Journal
Cancer Cell International
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-31
DOI
10.1186/s12935-021-02280-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway
- (2020) Yanfeng Liu et al. Nature Communications
- Regulatory Actions of Estrogen Receptor Signaling in the Cardiovascular System
- (2020) Kazutaka Ueda et al. Frontiers in Endocrinology
- The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway
- (2020) Liam Baird et al. MOLECULAR AND CELLULAR BIOLOGY
- The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway
- (2020) Tahereh Farkhondeh et al. BIOMEDICINE & PHARMACOTHERAPY
- Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer
- (2020) Azadeh Abravan et al. Journal of Thoracic Oncology
- Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
- (2020) Wamidh H. Talib et al. MOLECULES
- The impact of curcumin and its modified formulations on Alzheimer's disease
- (2019) Tahereh Farkhondeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice
- (2019) Meng Wu et al. Aging-US
- Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells
- (2019) Yongjun Li et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Nrf2 in cancers: A double‐edged sword
- (2019) Shijia Wu et al. Cancer Medicine
- Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway
- (2019) Xinyu Lin et al. PLoS One
- Nrf2–Keap1 pathway–mediated effects of resveratrol on oxidative stress and apoptosis in hydrogen peroxide–treated rheumatoid arthritis fibroblast‐like synoviocytes
- (2019) Ye Zhang et al. Annals of the New York Academy of Sciences
- Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation
- (2018) Xueyan Zhou et al. BIOCHEMICAL PHARMACOLOGY
- The Neuroprotective Effects of Thymoquinone: A Review
- (2018) Tahereh Farkhondeh et al. Dose-Response
- Radiotherapy and immune response: the systemic effects of a local treatment
- (2018) HA Carvalho et al. Clinics
- Thymoquinone-induced antitumor and apoptosis in human lung adenocarcinoma cells
- (2018) Saeed Samarghandian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Antioxidant activities of novel resveratrol analogs in breast cancer
- (2017) Anwesha Chatterjee et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Anti-oxidative effects of safranal on immobilization-induced oxidative damage in rat brain
- (2017) Saeed Samarghandian et al. NEUROSCIENCE LETTERS
- The PI3K/AKT Pathway as a Target for Cancer Treatment
- (2016) Ingrid A. Mayer et al. Annual Review of Medicine
- Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer
- (2016) Randall F Holcombe et al. Cancer Management and Research
- Resveratrol-loaded Nanoparticles Induce Antioxidant Activity against Oxidative Stress
- (2015) Jae-Hwan Kim et al. ASIAN-AUSTRALASIAN JOURNAL OF ANIMAL SCIENCES
- Skin resistance to oxidative stress induced by resveratrol: From Nrf2 activation to GSH biosynthesis
- (2015) J. Soeur et al. FREE RADICAL BIOLOGY AND MEDICINE
- The Phytoalexin Resveratrol Ameliorates Ochratoxin A Toxicity in Human Embryonic Kidney (HEK293) Cells
- (2015) Shanel Raghubeer et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men
- (2015) Thomas Nordstrøm Kjaer et al. PROSTATE
- Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice
- (2015) Hong Cai et al. Science Translational Medicine
- Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT
- (2014) Boram Lee et al. JOURNAL OF RADIOLOGICAL PROTECTION
- Synergistic inhibition of mesothelioma cell growth by the combination of clofarabine and resveratrol involves Nrf2 downregulation
- (2013) Yoon-Jin Lee et al. BMB Reports
- The emerging role of the Nrf2-Keap1 signaling pathway in cancer
- (2013) M. C. Jaramillo et al. GENES & DEVELOPMENT
- A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma
- (2012) Rakesh Popat et al. BRITISH JOURNAL OF HAEMATOLOGY
- Trans-Resveratrol Alters Mammary Promoter Hypermethylation in Women at Increased Risk for Breast Cancer
- (2012) Weizhu Zhu et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases--Safety, Pharmacokinetics, and Pharmacodynamics
- (2011) L. M. Howells et al. Cancer Prevention Research
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- A Systematic Review of Patient-Rated Measures of Radiodermatitis in Breast Cancer Radiotherapy
- (2010) Julie B. Schnur et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
- (2010) K. R. Patel et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started